Uterine Fibroid Treatment Market Will Reach USD 6,714.4 Million By 2030

The global uterine fibroid treatment market is projected to be USD 6,714.4 million by 2030 growing at a CAGR of 10.1% during the forecast period. This development can be credited to the increasing patient pool with uterine fibroids, the rising female elderly populace, the rising occurrence of hormonal circumstances among females, and altering lifestyles.

There has been a substantial rise in the occurrence of uterine fibroids among females worldwide in the past few years, particularly in their late 40s and early 50s. For example, according to a recent study in November 2022, an estimated occurrence of uterine fibroids is between 20% and 77%, and a projected occurrence is approximately 40-60% amongst females under the age of 35 years and 70-80% among females more than the age of 50 years.

Browse full report at: https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market

In 2022, based on uterine fibroid types, the intramural fibroids category had the largest industry share, of 60%. This growth can be credited to the growing incidence of intramural fibroids among females worldwide. Generally, this kind of fibroid can advance in the posterior, anterior, or fundal position, and appears to remain small in size as compared to other kinds of fibroids, although it can grow in large size. Additionally, the intramural fibroids do not usually swell outward or protrude into the uterine cavity and are entrenched in the muscular uterus wall. Thus, there is an increasing requirement for fast abdomen diagnosis.

In the coming few years, the surgical techniques category is projected to experience a CAGR of 11% during the projection period. This can be credited to the augmented occurrences of fibroids triggering moderate or severe symptoms, such as dangerous pain and heavy bleeding. Although medicines can aid in situations of mild symptoms, as a result, operating approaches are typically chosen by doctors for the removal of fibroids.

The North American region dominated the uterine fibroid treatment market, with a revenue share of 40% in 2022. This growth can be credited to the recognized healthcare market in the U.S. and Canada, the growing cases of uterine fibroids, the convenient availability of the latest tech, and the growing patient footfall suffering from hormonal syndromes and uterine cancers in the region. Moreover, government efforts, high repayment rates, and a surge in hysterectomies are further boosting the development of the industry for uterine fibroid treatment.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market/report-sample

Furthermore, the market growth in this region has been stimulated by established players such as Stryker Corp., Medtronic plc, Pfizer Inc., and Cooper Companies Inc., with their technological progress and novel treatments to treat uterus fibroids.

Hence, the increasing patient pool with uterine fibroids, the rising female elderly populace, the rising occurrence of hormonal circumstances among females, and altering lifestyles are the major factors driving the industry.

Market Size Breakdown by Segment

Based on Type
• Subserosal Fibroids
• Intramural Fibroids
• Submucosal Fibroids
• Pedunculated Fibroids
Based on Treatment
• Medication
o Levonorgestrel
o Gonadotropin-releasing hormone (GnRH) agonists
o Progestin-releasing intrauterine device (IUD)
o Tranexamic acid (Lysteda, Cyklokapron)
• Surgery
o Non-invasive
 MRI-guided focused ultrasound surgery
o Minimally invasive
 Uterine artery embolization
 Radiofrequency ablation
 Laparoscopic or robotic myomectomy
 Hysteroscopic myomectomy
 Endometrial ablation
o Traditional
 Abdominal myomectomy
 Hysterectomy
Based on End User
• Hospitals
• Ambulatory Surgery Centers
Geographical Analysis
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
• Latin America
o Brazil
o Mexico
• Middle East and Africa
o Saudi Arabia
o South Africa
o U.A.E.

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.